AAAAAA
Results:
1-7
|
Results: 7
Authors:
WANDINGER KP
BUBEL S
HENNIG H
SIEKHAUS A
TRILLENBERG P
WESSEL K
KIRCHNER H
Citation: Kp. Wandinger et al., ASSOCIATION BETWEEN DISEASE-ACTIVITY AND EPSTEIN-BARR-VIRUS REACTIVATION IN MULTIPLE-SCLEROSIS PATIENTS, Annals of neurology, 44(3), 1998, pp. 174-174
Authors:
HENNIG H
WESSEL K
SONDERMEIJER P
KIRCHNER H
WANDINGER KP
Citation: H. Hennig et al., LACK OF EVIDENCE FOR MAREKS-DISEASE VIRUS GENOMIC SEQUENCES IN LEUKOCYTE DNA FROM MULTIPLE-SCLEROSIS PATIENTS IN GERMANY, Neuroscience letters, 250(2), 1998, pp. 138-140
Authors:
WANDINGER KP
REISSLAND P
KIRCHNER H
WESSEL K
OTTO M
Citation: Kp. Wandinger et al., PRODUCTION OF ENDOGENOUS INTERFERON-ALPHA AND INTERFERON-BETA IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 1998, pp. 277-278
Authors:
WESSEL K
MOSCHNER C
WANDINGER KP
KOMPF D
HEIDE W
Citation: K. Wessel et al., OCULOMOTOR TESTING IN THE DIFFERENTIAL-DIAGNOSIS OF DEGENERATIVE ATAXIC DISORDERS, Archives of neurology, 55(7), 1998, pp. 949-956
Authors:
WANDINGER KP
WESSEL K
TRILLENBERG P
HEINDL N
KIRCHNER H
Citation: Kp. Wandinger et al., EFFECT OF HIGH-DOSE METHYLPREDNISOLONE ADMINISTRATION ON IMMUNE FUNCTIONS IN MULTIPLE-SCLEROSIS PATIENTS, Acta neurologica Scandinavica, 97(6), 1998, pp. 359-365
Authors:
WANDINGER KP
WESSEL K
NEUSTOCK P
SIEKHAUS A
KIRCHNER H
Citation: Kp. Wandinger et al., DIMINISHED PRODUCTION OF TYPE-I INTERFERONS AND INTERLEUKIN-2 IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 149(1), 1997, pp. 87-93
Authors:
MISSLER U
WANDINGER KP
WIESMANN M
KAPS M
WESSEL K
Citation: U. Missler et al., ACUTE EXACERBATION OF MULTIPLE-SCLEROSIS INCREASES PLASMA-LEVELS OF S-100 PROTEIN, Acta neurologica Scandinavica, 96(3), 1997, pp. 142-144
Risultati:
1-7
|